Dr. rer. nat. Dipl. -Ing. (FH) Matthias Goßmann holds a degree in biotechnology and a doctorate in chemistry. Since 2008, he has been working on the development of the CellDrum technology. He gained 3.5 years of experience as a scientist in stem cell industry (Axiogenesis AG) before turning to the field of business development as one of the two founders of innoVitro.
The second founder of innoVitro, Dipl. -Ing. (FH) Peter Linder MSc., has already contributed to the first development steps of the CellDrum technology in his diploma thesis in the field of biomedical technology. His further career includes a Master of Science in cooperation with the University Hospital of Cologne as well as project work in the field of aerospace technology. Besides his current doctorate on III. Physical Institute B at RWTH Aachen University, he is responsible at innoVitro for hardware and software development as well as laboratory management.
The team has been working together successfully for many years and complements each other excellently in its personal and professional qualities. Currently, the founders are working in a grant programme for high-tech start-ups to prepare the foundation of innoVitro.
Nanion Technologies, one of the world’s leading providers of cell-based assays, collaborates with innoVitro in the development of the CellDrum screening platform for cellular force measurement. Nanion will take over the production and distribution of the CellDrum device in close cooperation with innoVitro. The team of innoVitro is a member of the HESI Cardiac Safety Technical Committee, a consortium of pharmaceutical companies, technology providers, regulatory authorities and universities where new technologies are evaluated.